SEK 37.0
(-1.99%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -38.37 Million DKK | -40.36% |
2022 | -27.34 Million DKK | -15.03% |
2021 | -23.77 Million DKK | -36.14% |
2020 | -17.46 Million DKK | -80.88% |
2019 | -9.65 Million DKK | -16595.49% |
2018 | -57.81 Thousand DKK | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | -7.2 Million DKK | 4.23% |
2024 Q1 | -7.52 Million DKK | 39.28% |
2023 Q3 | -9.31 Million DKK | -30.47% |
2023 FY | -38.37 Million DKK | -40.36% |
2023 Q4 | -12.38 Million DKK | -32.99% |
2023 Q2 | -7.13 Million DKK | 25.13% |
2023 Q1 | -9.53 Million DKK | 10.04% |
2022 FY | -27.34 Million DKK | -15.03% |
2022 Q3 | -7.04 Million DKK | -22.47% |
2022 Q2 | -5.74 Million DKK | -45.43% |
2022 Q1 | -3.95 Million DKK | 50.15% |
2022 Q4 | -10.59 Million DKK | -50.53% |
2021 Q3 | -8.06 Million DKK | -81.77% |
2021 Q2 | -4.43 Million DKK | -32.73% |
2021 Q1 | -3.34 Million DKK | 48.55% |
2021 FY | -23.77 Million DKK | -36.14% |
2021 Q4 | -7.92 Million DKK | 1.69% |
2020 FY | -17.46 Million DKK | -80.88% |
2020 Q4 | -6.49 Million DKK | -182.6% |
2020 Q3 | -2.29 Million DKK | 58.77% |
2020 Q2 | -5.57 Million DKK | -80.57% |
2020 Q1 | -3.08 Million DKK | 0.8% |
2019 Q4 | -3.11 Million DKK | 23.08% |
2019 Q3 | -4.04 Million DKK | -162.79% |
2019 Q2 | -1.54 Million DKK | -61.59% |
2019 Q1 | -953 Thousand DKK | -1698.11% |
2019 FY | -9.65 Million DKK | -16595.49% |
2018 Q4 | -53 Thousand DKK | 0.0% |
2018 Q3 | - DKK | 0.0% |
2018 FY | -57.81 Thousand DKK | 0.0% |
2018 Q2 | - DKK | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
AddLife AB (publ) | 190 Million SEK | 120.198% |
Biotage AB (publ) | 246 Million SEK | 115.6% |
Bonesupport Holding AB (publ) | 245.02 Million SEK | 115.663% |
Doxa AB (publ) | 291.9 Million SEK | 113.147% |
Elekta AB (publ) | 1.3 Billion SEK | 102.948% |
iZafe Group AB (publ) | -32.17 Million SEK | -19.276% |
Ortivus AB (publ) | -18.24 Million SEK | -110.343% |
Ortivus AB (publ) | -18.24 Million SEK | -110.343% |
Q-linea AB (publ) | -229.36 Million SEK | 83.268% |
S2Medical AB (publ) | -22.7 Million SEK | -69.006% |
Synsam AB (publ) | 311 Million SEK | 112.34% |